Primary Job Title Board of Director Primary Organization 
Igenica
Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Female
LinkedIn View on LinkedIn
Gwen Fyfe, M.D., is an oncology biotechnology veteran with more than 20 years of drug development experience.Dr. Fyfe held various positions with Genentech, Inc. (now a member of the Roche Group) from 1997-2009, including vice president, oncology development and vice president, Avastin Franchise Team, as well as the honorary title of senior staff
scientist.
Fyfe played an important role in the development of Genentech’s approved oncology agents including Rituxan®, Herceptin®, Avastin® and Tarceva®.
Fyfe sat on the development oversight committee for all of Genentech’s products and participated in the Research Review Committee that moved products from research into clinical development. Since leaving Genentech in 2009, Fyfe has been a consultant for venture capital firms and for a variety of biotechnology companies.
Fyfe is a recognized oncology expert in the broader oncology community and has been an invited member of Institute of Medicine panels, National Cancer Institute working groups and grant committees and American Society of Clinical Oncologists oversight committees. She currently serves on the board of directors of Array BioPharma, Inc.
Fyfe is a graduate of Washington University School of Medicine and a board certified pediatric oncologist.
